Penumbra Stock (NYSE:PEN)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$242.07

52W Range

$148.00 - $277.34

50D Avg

$204.69

200D Avg

$207.92

Market Cap

$9.07B

Avg Vol (3M)

$409.19K

Beta

0.51

Div Yield

-

PEN Company Profile


Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,200

IPO Date

Sep 18, 2015

Website

PEN Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
Neuro$347.74M$338.71M$292.63M
Peripheral Vascular$499.39M$408.88M$267.78M

Fiscal year ends in Dec 23 | Currency in USD

PEN Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.06B$847.13M$747.59M
Operating Income$73.55M$-18.24M$-7.50M
Net Income$90.95M$-2.00M$2.62M
EBITDA$126.86M$6.08M$-7.50M
Basic EPS$2.37$-0.05$0.07
Diluted EPS$2.32$-0.05$0.07

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 11:45 PM
Q2 24Jul 30, 24 | 7:25 PM
Q1 24May 07, 24 | 12:00 AM

Peer Comparison


TickerCompany
TMDXTransMedics Group, Inc.
MASIMasimo Corporation
ITGRInteger Holdings Corporation
INMDInMode Ltd.
PODDInsulet Corporation
LIVNLivaNova PLC
IRTCiRhythm Technologies, Inc.
DXCMDexCom, Inc.
NARIInari Medical, Inc.
TNDMTandem Diabetes Care, Inc.
INSPInspire Medical Systems, Inc.
SWAVShockWave Medical, Inc.
CNMDCONMED Corporation